Lazzari, PaoloSpiga, MarcoSani, MonicaZanda, MatteoFleming, Ian N2017-05-252017-05-252017-05-23Lazzari, P, Spiga, M, Sani, M, Zanda, M & Fleming, I N 2017, 'KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation', Hypoxia, vol. 5, pp. 45-59. https://doi.org/10.2147/HP.S132832ORCID: /0000-0001-9505-6418/work/86450269http://hdl.handle.net/2164/8690151630699engSDG 3 - Good Health and Well-beingbreast cancertubulysinanti-mitotichypoxiacell deathreductaseR MedicineRKEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulationJournal article10.2147/HP.S1328325